QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PGEN

QT61Precigen, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
4.82
+0.09+1.90%
OverviewShort InterestFilings
PGENQT61Precigen, Inc.·NASDAQ
OverviewShort InterestFilings
4.82+1.90%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.28
Insider Own26.75%
Shs Outstand356.51M
Perf Week6.40%
Market Cap1.42BForward P/E23.93EPS next Y0.20Insider Trans-1.00%Shs Float-Perf Month15.87%
Enterprise Value1.51BPEG0.02EPS next Q-0.02Inst Own-Short Float-Perf Quarter45.18%
Income-196243848.00P/S44.98EPS this Y97.74%Inst Trans-Short Ratio-Perf Half Y24.55%
Sales31.59MP/B73.16EPS next Y796.40%ROA-147.46%Short Interest-Perf YTD15.31%
Book/sh0.06P/C-EPS next 5Y-ROE-1768.51%52W High5.47 -11.88%Perf Year239.44%
Cash/sh0.16P/FCF-EPS past 3/5Y-ROIC-79.18%52W Low1.38 249.28%Perf 3Y-
Dividend Est.-EV/EBITDA-7.75Sales past 3/5Y-28.19% -20.76%Gross Margin75.63%Volatility4.27% 4.48%Perf 5Y-
Dividend TTM-EV/Sales47.85EPS Y/Y TTM46.81%Oper. Margin-297.21%ATR (14)0.28Perf 10Y-
Dividend Ex-Date-Quick Ratio4.12Sales Y/Y TTM700.00%Profit Margin-646.99%RSI (14)64.07Recom2.38
Dividend Gr. 3/5Y-Current Ratio4.82EPS Q/Q71.43%SMA2014.10%Beta1.52Target Price14.00
Payout0.00%Debt/Eq4.86Sales Q/Q2200.00%SMA5015.55%Rel Volume1.19Prev Close4.73
Employees143LT Debt/Eq4.62EarningsAug 11SMA20019.76%Avg Volume4.01MPrice4.82
IPO DateAug 08, 2013Option/ShortYes / YesEPS/Sales Surpr.33.33% 9.52%Net Debt/EBITDA-0.47Volume4,755,603Change1.90%
Analyst Ratings
DateActionAnalystRatingTarget
May-28-26ReiteratedH.C. WainwrightBuy$11 → $14
May-14-26ReiteratedH.C. WainwrightBuy$10 → $11
Aug-15-25UpgradeJP MorganUnderweight → Neutral
Mar-22-24DowngradeJP MorganNeutral → Underweight
Aug-09-22ReiteratedH.C. WainwrightBuy$6.00
Mar-01-19DowngradeNorthland SecuritiesOutperform → Perform
Jul-16-18DowngradeBank of AmericaNeutral → Underperform
Nov-11-15UpgradeMizuhoUnderperform → Neutral
Nov-10-15UpgradeMizuhoUnderperform → Neutral
Aug-11-15DowngradeJP MorganOverweight → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue32104
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A864
Gross Profit2440
Selling, General and Administrative Excl. Other637041
Research and Development354053
Other Operating Expense19041
Operating Income-94-107-135
Interest Expense740
Unusual Expense
———
Non-Operating Income (Expense)105140-7
Net Income Before Taxes-205-251-128
Income Taxes00-2
Consolidated Net Income-205-251-126
Net Income From Continuing Operations-205-251-126
Net Income-205-251-126
EPS (Recurring)-1.28-1.41-0.47
EPS (Basic, Before Extraordinaries)-1.28-1.41-0.47
EPS (Diluted)-1.28-1.41-0.47
EBITDA-195-244-123
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio47.15127.49—
Gross Margin75.0040.000.00
Operating Margin-293.75-1,070.00-3,375.00
Net Margin-640.63-2,510.00-3,150.00
Shares Outstanding313305268
Market Capitalization1,5091,275—
Operating Lease Expense
———
Insider Trading Volume
$5.59$5.00$4.41$3.81$3.22● Close Price0.00M6.36M12.71M19.07M25.43MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Thomasian Harry Jr.Chief Financial OfficerMay 28 '26Sale4.3641,884182,614554,535Jun 01 12:00 AM
Shah Rutul RChief Operating OfficerMay 28 '26Sale4.3642,703186,185497,751Jun 01 12:00 AM
Lehr Donald P.Chief Legal OfficerMay 28 '26Sale4.3629,131127,011755,461Jun 01 12:00 AM
Sabzevari HelenPresident and CEOMay 28 '26Sale4.36119,250519,9303,768,872Jun 01 12:00 AM
Tennant PhilChief Commercial OfficerMay 28 '26Sale4.3630,272131,986139,369Jun 01 12:00 AM
Shah Rutul RChief Operating OfficerMay 23 '26Option Exercise0.00180,0000540,454May 27 12:00 AM
Sabzevari HelenPresident and CEOMay 23 '26Option Exercise0.00500,00003,888,122May 27 12:00 AM
Lehr Donald P.Chief Legal OfficerMay 23 '26Option Exercise0.00125,0000784,592May 27 12:00 AM
Thomasian Harry Jr.Chief Financial OfficerMay 23 '26Option Exercise0.00175,0000596,419May 27 12:00 AM
Tennant PhilChief Commercial OfficerMay 23 '26Option Exercise0.00125,0000169,641May 27 12:00 AM
KIRK RANDAL Jdirector, 10 percent owner:Mar 30 '26Sale3.304,772,78115,750,177302,213Mar 31 12:00 AM
Thomasian Harry Jr.Chief Financial OfficerMar 18 '26Option Exercise0.0080,5860508,919Mar 20 12:00 AM
Tennant PhilChief Commercial OfficerMar 18 '26Option Exercise0.0084,2200107,141Mar 20 12:00 AM
Sabzevari HelenPresident and CEOMar 18 '26Option Exercise0.00642,20003,638,122Mar 20 12:00 AM
Shah Rutul RChief Operating OfficerMar 18 '26Option Exercise0.0088,9900450,454Mar 20 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR